Introduction/Overview Histamine, a biogenic amine synthesized from the amino acid L-histidine, functions as a critical mediator in physiological and pathological processes. Its actions are primarily mediated through four distinct G-protein-coupled receptor subtypes: H1, H2, H3, and H4. Antihistamines, more precisely termed histamine receptor antagonists, are pharmacological agents that competitively inhibit the binding of histamine to … Read more
Introduction/Overview Gout represents a common and complex form of inflammatory arthritis characterized by the deposition of monosodium urate crystals in joints and other tissues, resulting from chronic hyperuricemia. The condition manifests through acute, intensely painful attacks, chronic arthropathy, and the potential development of tophi. The pharmacological management of gout is multifaceted, targeting both the acute … Read more
Introduction/Overview Gout is a common inflammatory arthritis characterized by the deposition of monosodium urate crystals in joints and other tissues, resulting from chronic hyperuricemia. The condition manifests as recurrent, intensely painful acute attacks and, if untreated, can progress to chronic tophaceous gout with joint destruction and renal impairment. The pharmacological management of gout is a … Read more
1. Introduction/Overview Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disorder characterized by persistent synovial inflammation, progressive joint destruction, and significant functional disability. The pharmacological management of RA has been fundamentally transformed by the development and clinical implementation of Disease-Modifying Antirheumatic Drugs (DMARDs). These agents are distinguished from purely symptomatic treatments, such as nonsteroidal anti-inflammatory … Read more
1. Introduction/Overview The management of rheumatoid arthritis (RA) and related autoimmune inflammatory arthropathies represents a cornerstone of clinical rheumatology and pharmacotherapy. Disease-modifying antirheumatic drugs (DMARDs) constitute the primary pharmacological intervention aimed not merely at symptom palliation but at altering the underlying disease course. The introduction of these agents has fundamentally transformed RA from a condition … Read more
Introduction/Overview Hematopoietic growth factors (HGFs) are a class of endogenous glycoproteins and their recombinant analogs that regulate the proliferation, differentiation, and functional activity of blood cell lineages. The clinical development and application of recombinant HGFs represent a pivotal advancement in supportive oncology and the management of various cytopenias. These agents have transformed patient care by … Read more
1. Introduction/Overview Hematinics constitute a fundamental class of therapeutic agents essential for the synthesis of hemoglobin and the normal maturation of erythrocytes. These substances, primarily comprising iron, vitamin B12 (cobalamin), and folic acid, serve as critical substrates or cofactors in biochemical pathways governing erythropoiesis. Deficiencies in any one of these hematinic factors can lead to … Read more
1. Introduction/Overview The fibrinolytic system represents a crucial endogenous mechanism for the removal of intravascular fibrin clots, thereby maintaining vascular patency. Pharmacological modulation of this system constitutes a cornerstone in the management of thrombotic and hemorrhagic disorders. Fibrinolytic agents, commonly termed thrombolytics, are employed to dissolve pathological thrombi, while antifibrinolytic agents are utilized to inhibit … Read more
Introduction/Overview Antiplatelet drugs constitute a cornerstone of pharmacotherapy for the prevention and management of atherothrombotic events. These agents function by inhibiting platelet activation, adhesion, and aggregation, thereby impeding the formation of occlusive thrombi within the arterial circulation. The clinical significance of these drugs is underscored by their central role in reducing morbidity and mortality associated … Read more
Introduction/Overview The fibrinolytic system represents a critical endogenous mechanism for the removal of intravascular fibrin deposits, thereby maintaining vascular patency. Pharmacological modulation of this system constitutes a cornerstone in the management of thrombotic and hemorrhagic disorders. Fibrinolytic agents, often termed thrombolytics, are employed to dissolve pathological thrombi, while antifibrinolytic agents are utilized to inhibit excessive … Read more